8-K Announcements
6Material company update
Apr 9, 2026·SEC
Material company update
Mar 30, 2026·SEC
Material company update
Jan 8, 2026·SEC
Neogen Corporation(NEOG)Earnings, Financials & Key Ratios
NEOG•NASDAQ
Price updated Jun 19, 2026
AboutNeogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.Show more
- Revenue$895M-3.2%
- EBITDA$135M-32.0%
- Net Income-$1.09B-11491.6%
- EPS (Diluted)-5.03-11463.2%
- Gross Margin47.1%-5.9%
- EBITDA Margin15.1%-29.7%
- Operating Margin1.05%-87.4%
- Net Margin-122.06%-11875.1%
- ROE-41.88%-13854.6%
NEOG Key Insights
Neogen Corporation (NEOG) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 16.4%
- ✓Trading at only 1.0x book value
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when NEOG posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NEOG Price & Volume
Neogen Corporation (NEOG) stock price & volume — 10-year historical chart
Loading chart...
NEOG Growth Metrics
Neogen Corporation (NEOG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years12.2%
5 Years16.43%
3 Years19.28%
TTM-3.67%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-26.54%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-26.51%
Return on Capital
10 Years8.14%
5 Years3.84%
3 Years1.14%
Last Year0.25%
NEOG Recent Earnings
Neogen Corporation (NEOG) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
Apr 9, 2026Metric
Actual
Est
EPS
$0.09+125.0%
$0.04
Rev
$211M+3.3%
$204M
Q1 2026
Jan 8, 2026Metric
Actual
Est
EPS
$0.10+42.9%
$0.07
Rev
$225M+8.2%
$208M
Q4 2025
Oct 9, 2025Metric
Actual
Est
EPS
$0.04+154.1%
$0.07
Rev
$209M+3.0%
$203M
Q3 2025
Jul 29, 2025Metric
Actual
Est
EPS
$0.05-37.5%
$0.08
Rev
$225M+11.2%
$203M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 9, 2026 | $0.09vs $0.04+125.0% | $211Mvs $204M+3.3% |
| Q1 2026 | Jan 8, 2026 | $0.10vs $0.07+42.9% | $225Mvs $208M+8.2% |
| Q4 2025 | Oct 9, 2025 | $0.04vs $0.07+154.1% | $209Mvs $203M+3.0% |
| Q3 2025 | Jul 29, 2025 | $0.05vs $0.08-37.5% | $225Mvs $203M+11.2% |
Based on last 12 quarters of dataView full earnings history →
NEOG Peer Comparison
Neogen Corporation (NEOG) competitors in Food, Water and Veterinary Diagnostics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 IDXX | 44.64B | 562.09 | 42.97 | 10.42% | 24.63% | 70.87% | 0.67 | |
 BCAL | 634.69M | 19.74 | 10.23 | 26.23% | 27.06% | 11.36% | 0.12 | |
 QDEL | 930.68M | 13.67 | -0.82 | -1.89% | -45.57% | -56.31% | 1.46 | |
 NVAX | 1.5B | 9.13 | 3.59 | 64.69% | -14.73% | |||
 BIO | 7.63B | 282.44 | 10.13 | 0.65% | 6.52% | 2.4% | 0.21 | |
 MESO | 1.85B | 14.37 | -17.11 | 191.39% | -5.94% | -17.1% | 0.21 | |
 FELE | 4.6B | 104.20 | 32.06 | 5.44% | 6.91% | 11.44% | 0.21 | |
 PRAX | 8.15B | 282.31 | -20.94 | -100% | -43.02% | 0.00 |
Compare NEOG vs Peers
Neogen Corporation (NEOG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NEOG Income Statement
Neogen Corporation (NEOG) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | May'17 | May'18 | May'19 | May'20 | May'21 | May'22 | May'23 | May'24 | May'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 361.59M | 397.93M | 414.19M | 418.17M | 468.46M | 527.16M | 822.45M | 924.22M | 894.66M | 880.32M |
Revenue Growth % | 12.55% | 10.05% | 4.09% | 0.96% | 12.03% | 12.53% | 56.02% | 12.37% | -3.2% | -3.67% |
Cost of Goods Sold | 189.63M | 211.66M | 222.27M | 221.89M | 253.4M | 284.15M | 416.49M | 461.59M | 473.29M | 545.36M |
COGS % of Revenue | 52.44% | 53.19% | 53.66% | 53.06% | 54.09% | 53.9% | 50.64% | 49.94% | 52.9% | - |
Gross Profit | 171.97M▲ 0% | 186.27M▲ 8.3% | 191.92M▲ 3.0% | 196.28M▲ 2.3% | 215.06M▲ 9.6% | 243.01M▲ 13.0% | 405.95M▲ 67.1% | 462.63M▲ 14.0% | 421.38M▼ 8.9% | 334.96M▲ 0% |
Gross Margin % | 47.56% | 46.81% | 46.34% | 46.94% | 45.91% | 46.1% | 49.36% | 50.06% | 47.1% | 38.05% |
Gross Profit Growth % | 12.35% | 8.32% | 3.03% | 2.27% | 9.57% | 13% | 67.05% | 13.96% | -8.92% | - |
Operating Expenses | 107.02M | 116.08M | 123.83M | 128.76M | 140.89M | 184.4M | 368.44M | 385.21M | 411.96M | 352.2M |
OpEx % of Revenue | 29.6% | 29.17% | 29.9% | 30.79% | 30.07% | 34.98% | 44.8% | 41.68% | 46.05% | - |
Selling, General & Admin | 96.64M | 105.22M | 111.02M | 114.01M | 124.64M | 167.35M | 342.4M | 382.76M | 399.91M | 411.56M |
SG&A % of Revenue | 26.73% | 26.44% | 26.8% | 27.26% | 26.61% | 31.74% | 41.63% | 41.41% | 44.7% | - |
Research & Development | 10.38M | 10.86M | 12.8M | 14.75M | 16.25M | 17.05M | 26.04M | 22.48M | 21.09M | 20.47M |
R&D % of Revenue | 2.87% | 2.73% | 3.09% | 3.53% | 3.47% | 3.23% | 3.17% | 2.43% | 2.36% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20.03M | -9.04M | -3M |
Operating Income | 64.94M▲ 0% | 70.19M▲ 8.1% | 68.09M▼ 3.0% | 67.52M▼ 0.8% | 74.17M▲ 9.8% | 58.62M▼ 21.0% | 37.52M▼ 36.0% | 77.43M▲ 106.4% | 9.42M▼ 87.8% | -17.24M▲ 0% |
Operating Margin % | 17.96% | 17.64% | 16.44% | 16.15% | 15.83% | 11.12% | 4.56% | 8.38% | 1.05% | -1.96% |
Operating Income Growth % | 15.18% | 8.08% | -2.99% | -0.84% | 9.84% | -20.97% | -36% | 106.39% | -87.83% | - |
EBITDA | 79.64M | 87.25M | 85.72M | 85.92M | 95.21M | 82.31M | 125.89M | 198.65M | 135.09M | 100.38M |
EBITDA Margin % | 22.02% | 21.93% | 20.7% | 20.55% | 20.32% | 15.61% | 15.31% | 21.49% | 15.1% | 11.4% |
EBITDA Growth % | 16.14% | 9.56% | -1.76% | 0.23% | 10.81% | -13.55% | 52.94% | 57.8% | -32% | -42.1% |
D&A (Non-Cash Add-back) | 14.69M | 17.06M | 17.62M | 18.4M | 21.04M | 23.69M | 88.38M | 121.23M | 125.67M | 117.62M |
EBIT | 66.67M | 73.47M | 72.96M | 72.31M | 75.27M | 60.21M | 33.92M | 61.37M | -1.06B | -551.33M |
Net Interest Income | 838K | 2.04M | 4.68M | 5.99M | 1.61M | 1.27M | -52.8M | -67.03M | -68.51M | -63.3M |
Interest Income | 838K | 2.04M | 4.68M | 5.99M | 1.69M | 1.34M | 3.17M | 6.36M | 3.11M | 2.85M |
Interest Expense | 0 | 0 | 0 | 0 | 78K | 72K | 55.96M | 73.39M | 71.62M | 66.16M |
Other Income/Expense | 1.73M | 3.27M | 4.87M | 4.78M | 1.1M | 1.59M | -59.56M | -91.73M | -1.14B | -600.25M |
Pretax Income | 66.67M▲ 0% | 73.47M▲ 10.2% | 72.96M▼ 0.7% | 72.31M▼ 0.9% | 75.27M▲ 4.1% | 60.21M▼ 20.0% | -22.04M▼ 136.6% | -14.3M▲ 35.1% | -1.13B▼ 7821.1% | -617.49M▲ 0% |
Pretax Margin % | 18.44% | 18.46% | 17.61% | 17.29% | 16.07% | 11.42% | -2.68% | -1.55% | -126.65% | -70.14% |
Income Tax | 22.7M | 10.25M | 12.78M | 12.83M | 14.39M | 11.9M | 828K | -4.88M | -41.07M | -14.75M |
Effective Tax Rate % | 34.05% | 13.95% | 17.52% | 17.74% | 19.11% | 19.77% | -3.76% | 34.14% | 3.62% | 2.39% |
Net Income | 43.79M▲ 0% | 63.15M▲ 44.2% | 60.18M▼ 4.7% | 59.48M▼ 1.2% | 60.88M▲ 2.4% | 48.31M▼ 20.7% | -22.87M▼ 147.3% | -9.42M▲ 58.8% | -1.09B▼ 11491.6% | -602.74M▲ 0% |
Net Margin % | 12.11% | 15.87% | 14.53% | 14.22% | 13% | 9.16% | -2.78% | -1.02% | -122.06% | -68.47% |
Net Income Growth % | 19.77% | 44.19% | -4.7% | -1.16% | 2.37% | -20.65% | -147.34% | 58.81% | -11491.59% | -26.54% |
Net Income (Continuing) | 43.97M | 63.22M | 60.18M | 59.48M | 60.88M | 48.31M | -22.87M | -9.42M | -1.09B | -602.74M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 143K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.43▲ 0% | 0.60▲ 39.5% | 0.57▼ 5.0% | 0.56▼ 1.8% | 0.57▲ 1.8% | 0.45▼ 21.1% | -0.12▼ 126.7% | -0.04▲ 63.8% | -5.03▼ 11463.2% | -2.77▲ 0% |
EPS Growth % | 19.44% | 39.53% | -5% | -1.75% | 1.79% | -21.05% | -126.67% | 63.75% | -11463.22% | -26.51% |
EPS (Basic) | 0.43 | 0.61 | 0.58 | 0.57 | 0.57 | 0.45 | -0.12 | -0.04 | -5.03 | - |
Diluted Shares Outstanding | 102.33M | 104.37M | 104.85M | 105.72M | 107.12M | 108.02M | 188.88M | 216.48M | 216.89M | 217.41M |
Basic Shares Outstanding | 101.86M | 103.47M | 103.78M | 105.1M | 106.5M | 107.68M | 188.88M | 216.48M | 216.89M | 217.41M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
NEOG Balance Sheet
Neogen Corporation (NEOG) balance sheet — assets, liabilities & shareholders' equity
| Metric | May'17 | May'18 | May'19 | May'20 | May'21 | May'22 | May'23 | May'24 | May'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 292.96M | 375.79M | 449.53M | 537.41M | 591.45M | 626.8M | 585.93M | 589.23M | 576.94M | 574.58M |
Cash & Short-Term Investments | 143.63M | 210.81M | 267.52M | 343.67M | 381.09M | 381.05M | 245.57M | 170.94M | 129M | 145.34M |
Cash Only | 77.57M | 83.07M | 41.69M | 66.27M | 75.6M | 44.47M | 163.24M | 170.61M | 129M | 145.34M |
Short-Term Investments | 66.07M | 127.74M | 225.84M | 277.4M | 305.49M | 336.58M | 82.33M | 325K | 0 | 0 |
Accounts Receivable | 68.58M | 79.09M | 82.58M | 84.68M | 91.82M | 99.67M | 153.25M | 173M | 153.38M | 132M |
Days Sales Outstanding | 69.22 | 72.54 | 72.78 | 73.91 | 71.54 | 69.01 | 68.01 | 68.32 | 62.58 | 60.53 |
Inventory | 73.14M | 76M | 85.99M | 95.05M | 100.7M | 122.31M | 133.81M | 189.27M | 190.86M | 162.77M |
Days Inventory Outstanding | 140.79 | 131.07 | 141.21 | 156.36 | 145.05 | 157.12 | 117.27 | 149.66 | 147.19 | 125.91 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 53.3M | 56.02M | 103.69M | 134.47M |
Total Non-Current Assets | 235.45M | 242.22M | 246.21M | 259.78M | 328.74M | 366.13M | 3.97B | 3.96B | 2.87B | 2.79B |
Property, Plant & Equipment | 61.75M | 73.07M | 74.85M | 78.67M | 100.45M | 110.58M | 198.75M | 291.89M | 356.28M | 347.46M |
Fixed Asset Turnover | 5.86x | 5.45x | 5.53x | 5.32x | 4.66x | 4.77x | 4.14x | 3.17x | 2.51x | 2.25x |
Goodwill | 104.76M | 99.56M | 103.62M | 110.34M | 131.48M | 142.7M | 2.14B | 2.14B | 1.06B | 1.05B |
Intangible Assets | 68.94M | 69.59M | 67.61M | 66.58M | 92.32M | 107.5M | 1.61B | 1.51B | 1.41B | 1.36B |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 229K | 0 | 0 |
Other Non-Current Assets | -6.77M | -3.97M | -15.48M | 647K | 620K | -1.59M | 7.77M | 20.2M | 35.23M | 32.5M |
Total Assets | 528.41M▲ 0% | 618.01M▲ 17.0% | 695.74M▲ 12.6% | 797.18M▲ 14.6% | 920.19M▲ 15.4% | 992.93M▲ 7.9% | 4.55B▲ 358.7% | 4.55B▼ 0.1% | 3.44B▼ 24.3% | 3.36B▲ 0% |
Asset Turnover | 0.68x | 0.64x | 0.60x | 0.52x | 0.51x | 0.53x | 0.18x | 0.20x | 0.26x | 0.25x |
Asset Growth % | 16.98% | 16.96% | 12.58% | 14.58% | 15.43% | 7.9% | 358.69% | -0.12% | -24.29% | -78.9% |
Total Current Liabilities | 36M | 38.69M | 38.25M | 48.49M | 53.6M | 77.84M | 145.47M | 154.32M | 174.01M | 147.05M |
Accounts Payable | 16.24M | 20.75M | 19.06M | 25.65M | 23.9M | 34.61M | 76.67M | 83.06M | 79.61M | 63.04M |
Days Payables Outstanding | 31.27 | 35.78 | 31.3 | 42.19 | 34.43 | 44.46 | 67.19 | 65.68 | 61.39 | 48.77 |
Short-Term Debt | 0 | 0 | 0 | 0 | 1.28M | 0 | 3.28M | 2.45M | 19.3M | 0 |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 3.4M | 5.46M | 4.62M | 4.63M | 5.56M | 21.02M |
Other Current Liabilities | 14.76M | 11.87M | 12.1M | 0 | 0 | 11.12M | 25.53M | 26.24M | 44.8M | 71.17M |
Current Ratio | 8.14x | 9.71x | 11.75x | 11.08x | 11.03x | 8.05x | 4.03x | 3.82x | 3.32x | 3.91x |
Quick Ratio | 6.11x | 7.75x | 9.50x | 9.12x | 9.16x | 6.48x | 3.11x | 2.59x | 2.22x | 2.80x |
Cash Conversion Cycle | 178.75 | 167.83 | 182.68 | 188.08 | 182.17 | 181.67 | 118.09 | 152.31 | 148.38 | 137.66 |
Total Non-Current Liabilities | 20.65M | 19.15M | 19.59M | 23.52M | 26.22M | 27.71M | 1.27B | 1.25B | 1.2B | 1.11B |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 885.44M | 888.39M | 874.81M | 792.93M |
Capital Lease Obligations | 0 | 0 | 0 | 913 | 0 | 0 | 8.81M | 10.3M | 12.86M | 12.86M |
Deferred Tax Liabilities | 17.05M | 14.1M | 15.62M | 18.13M | 21.92M | 17.01M | 353.43M | 326.72M | 280.91M | 1.13B |
Other Non-Current Liabilities | 3.6M | 5.04M | 3.97M | 5.39M | 4.3M | 10.7M | 27.07M | 24.96M | 29.99M | 41.54M |
Total Liabilities | 56.65M | 57.83M | 57.84M | 72M | 79.81M | 105.56M | 1.42B | 1.4B | 1.37B | 1.26B |
Total Debt | 0 | 0 | 0 | 1.05M | 1.29M | 0 | 897.53M | 906.24M | 912.61M | 792.93M |
Net Debt | -77.57M | -83.07M | -41.69M | -65.21M | -74.32M | -44.47M | 734.29M | 735.63M | 783.61M | 647.59M |
Debt / Equity | - | - | - | 0.00x | 0.00x | - | 0.29x | 0.29x | 0.44x | 0.38x |
Debt / EBITDA | - | - | - | 0.01x | 0.01x | - | 7.13x | 4.56x | 6.76x | 7.90x |
Net Debt / EBITDA | -0.97x | -0.95x | -0.49x | -0.76x | -0.78x | -0.54x | 5.83x | 3.70x | 5.80x | 6.45x |
Interest Coverage | - | - | - | - | 950.88x | 814.14x | 0.67x | 1.05x | 0.13x | -8.33x |
Total Equity | 471.9M▲ 0% | 560.17M▲ 18.7% | 637.9M▲ 13.9% | 725.18M▲ 13.7% | 840.38M▲ 15.9% | 887.37M▲ 5.6% | 3.13B▲ 253.2% | 3.14B▲ 0.3% | 2.07B▼ 34.1% | 2.1B▲ 0% |
Equity Growth % | 16.77% | 18.71% | 13.87% | 13.68% | 15.89% | 5.59% | 253.2% | 0.32% | -34.12% | -103.14% |
Book Value per Share | 4.61 | 5.37 | 6.08 | 6.86 | 7.85 | 8.21 | 16.59 | 14.52 | 9.55 | 9.68 |
Total Shareholders' Equity | 471.76M | 560.17M | 637.9M | 725.18M | 840.38M | 887.37M | 3.13B | 3.14B | 2.07B | 2.1B |
Common Stock | 8.15M | 8.28M | 8.36M | 16.94M | 17.2M | 17.25M | 34.6M | 34.66M | 34.73M | 34.8M |
Retained Earnings | 295.93M | 359.07M | 419.25M | 478.72M | 539.6M | 587.91M | 565.04M | 555.62M | -536.42M | -516.01M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -7.2M | -9.75M | -11.64M | -19.71M | -11.38M | -27.77M | -33.25M | -30.02M | -28.9M | -25.61M |
Minority Interest | 143K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NEOG Cash Flow Statement
Neogen Corporation (NEOG) cash flow — operating, investing & free cash flow history
| Metric | May'17 | May'18 | May'19 | May'20 | May'21 | May'22 | May'23 | May'24 | May'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 60.27M | 69.13M | 63.84M | 85.88M | 81.09M | 68.04M | 41.03M | 35.26M | 58.24M | 66.2M |
Operating CF Margin % | 16.67% | 17.37% | 15.41% | 20.54% | 17.31% | 12.91% | 4.99% | 3.82% | 6.51% | - |
Operating CF Growth % | 70.6% | 14.69% | -7.65% | 34.52% | -5.58% | -16.09% | -39.7% | -14.05% | 65.17% | 234.84% |
Net Income | 43.97M | 63.22M | 60.18M | 59.48M | 60.88M | 48.31M | -22.87M | -9.42M | -1.09B | -602.74M |
Depreciation & Amortization | 14.69M | 17.06M | 17.62M | 18.4M | 21.04M | 24.13M | 90.47M | 121.23M | 125.67M | 123.81M |
Stock-Based Compensation | 5.26M | 4.91M | 5.54M | 6.47M | 6.44M | 7.15M | 10.18M | 13.77M | 17.29M | 17.79M |
Deferred Taxes | -292K | -3M | 1.2M | 1.6M | -640K | -4.7M | -19.23M | -27.42M | -57.78M | -45.09M |
Other Non-Cash Items | -3.92M | 0 | 0 | 0 | 0 | -2.44M | 6.67M | 9.8M | 1.07B | 526.26M |
Working Capital Changes | 563K | -13.05M | -20.7M | -62K | -6.63M | -4.42M | -24.2M | -72.68M | -5.93M | 46.17M |
Change in Receivables | 5.04M | -10.23M | -4.03M | -2.88M | -2.6M | -7.8M | -53.88M | -20.1M | 11.64M | 17.65M |
Change in Inventory | -6.97M | -2.65M | -10.44M | -10.01M | 2.45M | -21.07M | 9.96M | -55.95M | -16.12M | 17.99M |
Change in Payables | -1.69M | 4.38M | -1.46M | 6.75M | -2.22M | 20.24M | 18.64M | 13.75M | -402K | 2.29M |
Cash from Investing | -62.14M | -83.08M | -119.15M | -88.78M | -105.56M | -97.23M | 201.04M | -29.31M | -99.19M | 37.68M |
Capital Expenditures | -14.58M | -20.95M | -14.66M | -24.05M | -26.71M | -24.43M | -65.76M | -111.42M | -104.59M | -84.68M |
CapEx % of Revenue | 4.03% | 5.26% | 3.54% | 5.75% | 5.7% | 4.63% | 8% | 12.06% | 11.69% | 9.62% |
Acquisitions | -34.03M | -468K | -6.39M | -13.16M | -50.77M | -38.74M | 12.55M | 108K | 5.08M | 122.36M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | 25.07M | 22.84M | 13.9M | 29.41M | 33.54M | 6.81M | -118.08M | 1.92M | -1.6M | -101.01M |
Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | -100M | -420K | -321K | -100.22M |
Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 2M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | -3.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 3.92M | -423K | 0 | 0 | -1.09M | -1.12M | -19.28M | -118K | -3.52M | -4.09M |
Net Change in Cash | 22.31M▲ 0% | 5.51M▼ 75.3% | -41.39M▼ 851.5% | 24.58M▲ 159.4% | 9.33M▼ 62.0% | -31.13M▼ 433.5% | 118.77M▲ 481.5% | 7.37M▼ 93.8% | -41.61M▼ 664.5% | 5.11M▲ 0% |
Free Cash Flow | 45.7M▲ 0% | 48.19M▲ 5.4% | 49.18M▲ 2.1% | 61.83M▲ 25.7% | 54.38M▼ 12.0% | 43.61M▼ 19.8% | -24.73M▼ 156.7% | -76.16M▼ 208.0% | -46.35M▲ 39.1% | 17.2M▲ 0% |
FCF Margin % | 12.64% | 12.11% | 11.87% | 14.78% | 11.61% | 8.27% | -3.01% | -8.24% | -5.18% | 1.95% |
FCF Growth % | 116.48% | 5.45% | 2.07% | 25.71% | -12.05% | -19.8% | -156.71% | -207.97% | 39.14% | 118.44% |
FCF per Share | 0.45 | 0.46 | 0.47 | 0.58 | 0.51 | 0.40 | -0.13 | -0.35 | -0.21 | 0.08 |
FCF Conversion (FCF/Net Income) | 1.38x | 1.09x | 1.06x | 1.44x | 1.33x | 1.41x | -1.79x | -3.74x | -0.05x | -0.03x |
Interest Paid | 0 | 0 | 0 | 0 | 78K | 72K | 42.62M | 73.17M | 68.14M | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 14.97M | 17.24M | 15.47M | 22.3M | 26.54M | 0 |
NEOG Key Ratios
Neogen Corporation (NEOG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 10% | 12.24% | 10.05% | 8.73% | 7.78% | 5.59% | -1.14% | -0.3% | -41.88% | -28.64% |
Return on Invested Capital (ROIC) | 13.11% | 12.08% | 9.52% | 8.06% | 7.8% | 5.46% | 1.19% | 1.5% | 0.21% | -0.44% |
Gross Margin | 47.56% | 46.81% | 46.34% | 46.94% | 45.91% | 46.1% | 49.36% | 50.06% | 47.1% | 38.05% |
Net Margin | 12.11% | 15.87% | 14.53% | 14.22% | 13% | 9.16% | -2.78% | -1.02% | -122.06% | -68.47% |
Debt / Equity | - | - | - | 0.00x | 0.00x | - | 0.29x | 0.29x | 0.44x | 0.38x |
Interest Coverage | - | - | - | - | 950.88x | 814.14x | 0.67x | 1.05x | 0.13x | -8.33x |
FCF Conversion | 1.38x | 1.09x | 1.06x | 1.44x | 1.33x | 1.41x | -1.79x | -3.74x | -0.05x | -0.03x |
Revenue Growth | 12.55% | 10.05% | 4.09% | 0.96% | 12.03% | 12.53% | 56.02% | 12.37% | -3.2% | -3.67% |
Related:NEOG Dividend History·NEOG Revenue History·NEOG Price History·NEOG P/E History·NEOG Financial Ratios·NEOG Institutional Holders
NEOG SEC Filings & Documents
Neogen Corporation (NEOG) SEC filings — annual & quarterly reports (10-K, 10-Q)
NEOG Frequently Asked Questions
Neogen Corporation (NEOG) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Neogen Corporation (NEOG) reported $880.3M in revenue for fiscal year 2025. This represents a 6943% increase from $12.5M in 1996.
Neogen Corporation (NEOG) saw revenue decline by 3.2% over the past year.
Neogen Corporation (NEOG) reported a net loss of $602.7M for fiscal year 2025.
Dividend & Returns
Neogen Corporation (NEOG) has a return on equity (ROE) of -41.9%. Negative ROE indicates the company is unprofitable.
Neogen Corporation (NEOG) generated $17.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.